Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese.
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Leptin (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 30 Apr 2013 Planned End Date 1 Jul 2015 added as reported by ClinicalTrials.gov.
- 30 Apr 2013 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
- 23 Jan 2010 New trial record